Golden Pen Award | Research Progress on the Application of Exosomes in Drug Delivery
Exosomes are specific membrane vesicles secreted by various types of cells under normal or pathological conditions, playing a vital role in intercellular communication and exchange of information.
September 2, 2025
by Xiaonisha
Golden Pen Award | The Current Status of Application of Biomembrane Nanocarrier Drug Delivery Systems in Tumor Immunotherapy
In recent years, the excellent biocompatibility, modifiability, and low immunogenicity of biomembrane nanosystems have significantly advanced the development of tumor immunotherapy.
August 27, 2025
by Xiaonisha
Astragalus Membranaceus Processing and Its Development and Application Prospects
Astragalus membranaceus is the dried root of the leguminous plant Astragalus membranaceus var. mongholicus or Astragalus membranaceus (A. membranaceus).
August 20, 2025
by Xiaonisha
The Pharmacological Effects and Application Prospects of Puerarin
Puerarin, also known as Puerarin, is a natural isoflavone C-glycoside and the key component responsible for the medicinal effects of kudzu.
August 15, 2025
by Xiaonisha
2025 Q1: Oncology Business Competition Among MNCs
How did MNCs fare in the oncology field during Q1 of this year?
June 4, 2025
by Xiaobin
The Classification of Sesquiterpene Compounds and Their Research Progress
Terpenoids are an important part of natural organic compounds, and there are currently more than 50,000 reported terpenoid structures.
May 23, 2024
by Xiaomichong
Competitive Landscape of the New Drug Target Nectin-4 in China
Araris Biotech AG announced on April 17 that it will acquire ARS Pharmaceutical's Nectin-4 antibody. Araris Biotech intends to use the acquired Nectin-4 antibody to develop differentiated Nectin-4 ADCs using its proprietary linker technology.
May 22, 2023
by Yefenghong/PharmaSources
Data of InnoCare’s Robust Oncology Pipelines Presented at the 2023 AACR Annual Meeting
April 18, 2023,Data of InnoCare’s robust oncology pipelines were presented at the 2023 American Association for Cancer Research (AACR) Annual Meeting.
April 18, 2023
by PharmaSources
Immune-Based Therapy Shows Promise Against Advanced Breast Cancers
An experimental therapy that harnesses the body's tumor-fighting immune cells...
February 9, 2022
by drugs.com
Pre-Op Treatment May Be Advance Against Deadly Liver Cancers
When delivering a liver cancer diagnosis, Dr. Thomas Marron pulls no punches: "Liver cancer is one of the deadliest cancers," he tells patients.
January 28, 2022
by drugs.com
FDA Accepts Rakuten Medical’s IND Application for Oncology Candidate
Will begin clinical studies of RM-1995 photoimmunotherapy in advanced head and neck cancer.
December 17, 2021
by contractpharma
A New Target in ADC: Nectin-4
Recently, the application for clinical trail of Mabwell's ADC drug (9MW2821) targeting Nectin-4 has been accepted by NMPA. It is the first time that domestic enterprise enters the IND stage with the same target drug.
September 14, 2021
by PharmaSources/Yefenghong